CGTX: Cognition Therapeutics, Inc. Stock

by  •  • Comments Off on CGTX: Cognition Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 76.05
Enterprise Value ($M) 46.67
Book Value ($M) 24.47
Book Value / Share 0.63
Price / Book 3.11
NCAV ($M) 23.53
NCAV / Share 0.60
Price / NCAV 3.23

Profitability (mra)
Return on Invested Capital (ROIC) -1.00
Return on Assets (ROA) -0.56
Return on Equity (ROE) -0.72

Liquidity (mrq)
Quick Ratio 3.37
Current Ratio 3.37

Balance Sheet (mrq) ($M)
Current Assets 34.22
Assets 35.16
Liabilities 10.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -50.72
Net Income -25.79
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -16.02
Cash from Investing -0.15
Cash from Financing 4.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-07 13G/A Hirschman Orin 4.80 -28.93
01-19 13G Pathstone Family Office, Llc 7.53
11-13 13D/A BIOS Memory SPV I, LP 19.40 8.91

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 10,286 54,748 18.79
2024-04-25 49,934 133,323 37.45
2024-04-24 19,451 35,822 54.30
2024-04-23 22,142 16,281 136.00
2024-04-22 22,432 28,261 79.37

(click for more detail)

Similar Companies
CADL – Candel Therapeutics, Inc. CARA – Cara Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc. CHRS – Coherus BioSciences, Inc.
CLSD – Clearside Biomedical, Inc.


Financial data and stock pages provided by
Fintel.io